Compare GNLX & CEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GNLX | CEV |
|---|---|---|
| Founded | 2001 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 202.4M | 70.8M |
| IPO Year | 2023 | N/A |
| Metric | GNLX | CEV |
|---|---|---|
| Price | $4.33 | $10.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $19.75 | N/A |
| AVG Volume (30 Days) | ★ 187.8K | 19.6K |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.23% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.36 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $29.36 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.99 | $8.83 |
| 52 Week High | $8.54 | $10.91 |
| Indicator | GNLX | CEV |
|---|---|---|
| Relative Strength Index (RSI) | 35.71 | 37.65 |
| Support Level | $4.37 | $10.35 |
| Resistance Level | $4.75 | $10.42 |
| Average True Range (ATR) | 0.42 | 0.08 |
| MACD | -0.04 | -0.03 |
| Stochastic Oscillator | 8.99 | 0.00 |
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
Eaton Vance CA Muni Income Trust is a non-diversified closed-end investment company. The company's investment objective is to provide current income exempt from regular federal income tax and California state personal income taxes. It invests in municipal obligations, issued by the State of California or its political subdivisions, agencies, authorities and instrumentalities and also has some exposure to corporate bonds.